Ofatumumab, Multiple Sclerosis Drug Candidate, Shows Promise In Phase 2 Study
Category: WELLNESS
"We are encouraged by the results from this study," Genmab's chief executive Jan van de Winkel said in the statement. There
By Reuters, Reuters, 2013-10-10